Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01484314 · BASELINE

Baseline characteristics

Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma · Source last updated 2017-03-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      1
    units
    Participants
groups
  1. description
    Administration of eltrombopag to support platelets during chemotherapy Eltrombopag: 100mg (patients of East Asian descent will receive a dose of 50mg) orally dosed once daily starting 6 days prior to initiation of chemotherapy for a total of 11 days of treatment during two consecutive cycles of chemotherapy
    id
    BG000
    title
    Migration Arm
measures
  1. classes
    1. categories
      1. title
        <=18 years
      2. title
        Between 18 and 65 years
      3. title
        >=65 years
      denoms
      1. counts
        1. group Id
          BG000
          value
          0
        units
        Participants
    param Type
    COUNT_OF_PARTICIPANTS
    population Description
    Terminated with 1 patient enrolled; no data due to patient privacy.
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. title
        Female
      2. title
        Male
      denoms
      1. counts
        1. group Id
          BG000
          value
          0
        units
        Participants
    param Type
    COUNT_OF_PARTICIPANTS
    population Description
    Terminated with 1 patient enrolled; no data due to patient privacy.
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. denoms
      1. counts
        1. group Id
          BG000
          value
          0
        units
        Participants
      title
      United States
    param Type
    NUMBER
    population Description
    Terminated with 1 patient enrolled; no data due to patient privacy.
    title
    Region of Enrollment
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      1
    units
    Participants
groups
  1. description
    Administration of eltrombopag to support platelets during chemotherapy Eltrombopag: 100mg (patients of East Asian descent will receive a dose of 50mg) orally dosed once daily starting 6 days prior to initiation of chemotherapy for a total of 11 days of treatment during two consecutive cycles of chemotherapy
    id
    BG000
    title
    Migration Arm
measures
  1. classes
    1. categories
      1. title
        <=18 years
      2. title
        Between 18 and 65 years
      3. title
        >=65 years
      denoms
      1. counts
        1. group Id
          BG000
          value
          0
        units
        Participants
    param Type
    COUNT_OF_PARTICIPANTS
    population Description
    Terminated with 1 patient enrolled; no data due to patient privacy.
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. title
        Female
      2. title
        Male
      denoms
      1. counts
        1. group Id
          BG000
          value
          0
        units
        Participants
    param Type
    COUNT_OF_PARTICIPANTS
    population Description
    Terminated with 1 patient enrolled; no data due to patient privacy.
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. denoms
      1. counts
        1. group Id
          BG000
          value
          0
        units
        Participants
      title
      United States
    param Type
    NUMBER
    population Description
    Terminated with 1 patient enrolled; no data due to patient privacy.
    title
    Region of Enrollment
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice